Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

On the trail of yellow fever.

Kean S.

Science. 2017 Aug 18;357(6352):637-641. doi: 10.1126/science.357.6352.637. No abstract available.

PMID:
28818926
2.

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.

Petrie JR, Chaturvedi N, Ford I, Brouwers MCGJ, Greenlaw N, Tillin T, Hramiak I, Hughes AD, Jenkins AJ, Klein BEK, Klein R, Ooi TC, Rossing P, Stehouwer CDA, Sattar N, Colhoun HM; REMOVAL Study Group.

Lancet Diabetes Endocrinol. 2017 Aug;5(8):597-609. doi: 10.1016/S2213-8587(17)30194-8. Epub 2017 Jun 11.

PMID:
28615149
3.

Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin.

Raizman Z, Hosseini B, Kean S, Altman AD.

Gynecol Oncol Rep. 2017 Apr 5;20:112-114. doi: 10.1016/j.gore.2017.04.001. eCollection 2017 May.

4.

Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.

Stott DJ, Rodondi N, Kearney PM, Ford I, Westendorp RGJ, Mooijaart SP, Sattar N, Aubert CE, Aujesky D, Bauer DC, Baumgartner C, Blum MR, Browne JP, Byrne S, Collet TH, Dekkers OM, den Elzen WPJ, Du Puy RS, Ellis G, Feller M, Floriani C, Hendry K, Hurley C, Jukema JW, Kean S, Kelly M, Krebs D, Langhorne P, McCarthy G, McCarthy V, McConnachie A, McDade M, Messow M, O'Flynn A, O'Riordan D, Poortvliet RKE, Quinn TJ, Russell A, Sinnott C, Smit JWA, Van Dorland HA, Walsh KA, Walsh EK, Watt T, Wilson R, Gussekloo J; TRUST Study Group.

N Engl J Med. 2017 Jun 29;376(26):2534-2544. doi: 10.1056/NEJMoa1603825. Epub 2017 Apr 3.

PMID:
28402245
5.

Realizing the Promise of the Global Plan: Engaging Communities and Promoting the Health and Human Rights of Women Living With HIV.

Matheson R, Brion S, Sharma A, Dilmitis S, Schmitz K, Kean S, Filous K, Murenga M, Scheepers E, Ukoli P, Mworeko L, Yuvaraj A.

J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S86-S93. doi: 10.1097/QAI.0000000000001330. Review.

PMID:
28399001
6.

A family intervention to reduce delirium in hospitalised ICU patients: A feasibility randomised controlled trial.

Mitchell ML, Kean S, Rattray JE, Hull AM, Davis C, Murfield JE, Aitken LM.

Intensive Crit Care Nurs. 2017 Jun;40:77-84. doi: 10.1016/j.iccn.2017.01.001. Epub 2017 Feb 27.

PMID:
28254205
7.

Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST).

Stott DJ, Gussekloo J, Kearney PM, Rodondi N, Westendorp RG, Mooijaart S, Kean S, Quinn TJ, Sattar N, Hendry K, Du Puy R, Den Elzen WP, Poortvliet RK, Smit JW, Jukema JW, Dekkers OM, Blum M, Collet TH, McCarthy V, Hurley C, Byrne S, Browne J, Watt T, Bauer D, Ford I.

BMC Endocr Disord. 2017 Feb 3;17(1):6. doi: 10.1186/s12902-017-0156-8.

8.

Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial.

Petrie JR, Chaturvedi N, Ford I, Hramiak I, Hughes AD, Jenkins AJ, E Klein B, Klein R, Ooi TC, Rossing P, Sattar N, Stehouwer CD, Colhoun HM; REMOVAL Trial Team.

Diabetes Obes Metab. 2017 Apr;19(4):509-516. doi: 10.1111/dom.12840. Epub 2017 Feb 17.

9.

The scientific night shift.

Kean S.

Science. 2016 Nov 25;354(6315):988-991. No abstract available.

PMID:
27885002
10.

'Intensive care unit survivorship' - a constructivist grounded theory of surviving critical illness.

Kean S, Salisbury LG, Rattray J, Walsh TS, Huby G, Ramsay P.

J Clin Nurs. 2016 Nov 22. doi: 10.1111/jocn.13659. [Epub ahead of print]

PMID:
27875013
11.

Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings.

Conway DI, Robertson C, Gray H, Young L, McDaid LM, Winter AJ, Campbell C, Pan J, Kavanagh K, Kean S, Bhatia R, Cubie H, Clarkson JE, Bagg J, Pollock KG, Cuschieri K.

PLoS One. 2016 Nov 18;11(11):e0165847. doi: 10.1371/journal.pone.0165847. eCollection 2016.

12.

Patient, family-centred care interventions within the adult ICU setting: An integrative review.

Mitchell ML, Coyer F, Kean S, Stone R, Murfield J, Dwan T.

Aust Crit Care. 2016 Nov;29(4):179-193. doi: 10.1016/j.aucc.2016.08.002. Epub 2016 Sep 1. Review.

PMID:
27592540
13.

Patient and carer experience of hospital-based rehabilitation from intensive care to hospital discharge: mixed methods process evaluation of the RECOVER randomised clinical trial.

Ramsay P, Huby G, Merriweather J, Salisbury L, Rattray J, Griffith D, Walsh T; RECOVER collaborators.

BMJ Open. 2016 Aug 1;6(8):e012041. doi: 10.1136/bmjopen-2016-012041.

14.

Community participation for transformative action on women's, children's and adolescents' health.

Marston C, Hinton R, Kean S, Baral S, Ahuja A, Costello A, Portela A.

Bull World Health Organ. 2016 May 1;94(5):376-82. doi: 10.2471/BLT.15.168492. Epub 2016 May 2.

15.

Systemic inflammation after critical illness: relationship with physical recovery and exploration of potential mechanisms.

Griffith DM, Lewis S, Rossi AG, Rennie J, Salisbury L, Merriweather JL, Templeton K, Walsh TS; RECOVER Investigators.

Thorax. 2016 Sep;71(9):820-9. doi: 10.1136/thoraxjnl-2015-208114. Epub 2016 Apr 26.

PMID:
27118812
16.

The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial.

Leslie WS, Ford I, Sattar N, Hollingsworth KG, Adamson A, Sniehotta FF, McCombie L, Brosnahan N, Ross H, Mathers JC, Peters C, Thom G, Barnes A, Kean S, McIlvenna Y, Rodrigues A, Rehackova L, Zhyzhneuskaya S, Taylor R, Lean ME.

BMC Fam Pract. 2016 Feb 16;17:20. doi: 10.1186/s12875-016-0406-2.

17.

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.

Brown MJ, Williams B, Morant SV, Webb DJ, Caulfield MJ, Cruickshank JK, Ford I, McInnes G, Sever P, Salsbury J, Mackenzie IS, Padmanabhan S, MacDonald TM; British Hypertension Society's Prevention and Treatment of Hypertension with Algorithm-based Therapy (PATHWAY) Studies Group.

Lancet Diabetes Endocrinol. 2016 Feb;4(2):136-47. doi: 10.1016/S2213-8587(15)00377-0. Epub 2015 Oct 18.

18.

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ; British Hypertension Society's PATHWAY Studies Group.

Lancet. 2015 Nov 21;386(10008):2059-68. doi: 10.1016/S0140-6736(15)00257-3. Epub 2015 Sep 20.

19.

Increased Hospital-Based Physical Rehabilitation and Information Provision After Intensive Care Unit Discharge: The RECOVER Randomized Clinical Trial.

Walsh TS, Salisbury LG, Merriweather JL, Boyd JA, Griffith DM, Huby G, Kean S, Mackenzie SJ, Krishan A, Lewis SC, Murray GD, Forbes JF, Smith J, Rattray JE, Hull AM, Ramsay P; RECOVER Investigators.

JAMA Intern Med. 2015 Jun;175(6):901-10. doi: 10.1001/jamainternmed.2015.0822.

PMID:
25867659
20.

Cause of death.

Kean S.

Science. 2015 Mar 27;347(6229):1410-3. doi: 10.1126/science.347.6229.1410. No abstract available.

PMID:
25814566

Supplemental Content

Loading ...
Support Center